Discover 2,717 paid clinical trials in Ontario. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Filter
1
Filter results
Results: 2,717
Longitudinal Study for Eosinophilic Granulomatosis With Polyangiitis
for
Eosinophilic Granulomatosis With Polyangiitis,
Location: Hamilton
Sponsor: University of Pennsylvania
Sex: All
Age: 0+
Code: NCT00315380
Recruiting
Real Time MRI Fused to Cone Beam CT Guided Biopsies of the Prostate.
for
Prostate Cancer
Location: Kingston
Sponsor: Queen's University
Sex: Male
Age: 18+
Code: NCT04180592
Recruiting
Optimizing Recruitment to Drive Equitable Research Opportunity in Stroke Rehabilitation Trials in Canada
for
Stroke
Location: Halifax, London, Calgary, Vancouver
Sponsor: McMaster University
Sex: All
Age: 18+
Code: NCT06576089
Recruiting
Apple-CPET Ted Rogers Understanding Exacerbations of Heart Failure
for
Heart Failure, Heart Failure, Systolic,
Location: Toronto
Sponsor: University Health Network, Toronto
Sex: All
Age: 18+
Code: NCT05008692
Recruiting
Consolidative Prostate Radiotherapy in Metastatic Prostate Cancer
for
Prostate Metastases
Location: Toronto
Sponsor: University Health Network, Toronto
Sex: Male
Age: 18 - 70+
Code: NCT05656794
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases
for
Brain Metastases
Location: Halifax, Boston MA, Quebec, Egg Harbor NJ, Montreal,
Sponsor: Canadian Cancer Trials Group
Sex: All
Age: 18+
Code: NCT03550391
Phase3, Recruiting
Incretin and Treatment With Inhibition of Sodium-glucose Cotransporter-2 Combination Insights Into Mechanisms Implicated in Congestive Heart Failure: "NATRIURETIC" Trial
for
Type 2 Diabetes Mellitus
Location: Toronto
Sponsor: University Health Network, Toronto
Sex: All
Age: 18+
Code: NCT04535960
Phase2, Recruiting
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo
for
NonSegmental Vitiligo
Location: St. John's, Halifax, Boston MA, Quebec, Woodbury NY,
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
for
COPD (Chronic Obstructive Pulmonary Disease)
Location: Sydney, Boston MA, Quebec, Massapequa NY, The Bronx NY,
Sponsor: AstraZeneca
Sex: All
Age: 40 - 70+
Code: NCT06283966
Phase3, Recruiting
Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG
for
Atrial Fibrillation, Stroke, Bleeding
Location: Portland ME, Boston MA, New Haven CT, Lebanon NH,
Sponsor: Icahn School of Medicine at Mount Sinai
Sex: All
Age: 18+
Code: NCT04045665
Phase3, Recruiting
Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma
Location: New York NY, Philadelphia PA, Baltimore MD,
Sponsor: Jazz Pharmaceuticals
Sex: All
Age: 2 - 30
Code: NCT05734066
Phase1, Phase2, Recruiting
FitJoints: Getting Fit for Hip and Knee Replacement
for
Hip Osteoarthritis, Knee Osteoarthritis
Location: Hamilton
Sponsor: McMaster University
Sex: All
Age: 60+
Code: NCT05100966
Recruiting
A Randomized Phase III Trial of Stereotactic Ablative Radiotherapy for Patients With Up to 10 Oligometastases and a Synchronous Primary Tumor.
for
Metastatic Tumor
Location: Montreal, London, Vancouver
Sponsor: David Palma
Sex: All
Age: 18+
Code: NCT05717166
Phase3, Recruiting
Pilot Feasibility and Safety of Administering Weight Adjusted Fixed LMWH Dose
for
Venous Thromboembolism
Location: Halifax, Philadelphia PA, Hamilton
Sponsor: Hamilton Health Sciences Corporation
Sex: All
Age: 0 - 18
Code: NCT02486666
Phase3, Recruiting
Pneumatic Retinopexy for Primary Rhegmatogenous Retinal Detachment: To Steamroll or Not
for
Rhegmatogenous Retinal Detachment
Location: Toronto
Sponsor: Sunnybrook Health Sciences Centre
Sex: All
Age: 18+
Code: NCT04723420
Recruiting
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
for
Metastatic Castration-resistant Prostate Cancer (mCRPC),
Location: New Haven CT, Quebec, New Brunswick NJ, Montreal,